
Trump to Impose 100% Tariff on Indian Generic Drugs in 2028
The story in brief
Trump has announced a 100% tariff on imported generic drugs starting August 2028, targeting India, the largest exporter of such medicines to the US. The move, aimed at addressing drug affordability ahead of the 2026 midterms, would impact over 40% of India’s exports, adding to existing tariffs on steel, aluminum, and autos. Generic manufacturers, reliant on global supply chains, face significant challenges absorbing these costs.